More about

Bupivacaine

News
April 05, 2024
1 min read
Save

Liposomal bupivacaine may augment pain management for spinal fusion

Liposomal bupivacaine may augment pain management for spinal fusion

Results showed patients who received liposomal bupivacaine for pain management during open posterior lumbar decompression and fusion required less opioids during their hospital stay vs. patients who did not receive the anesthetic.

News
January 26, 2024
1 min read
Save

Heron Therapeutics receives expanded indications from the FDA for Zynrelef

Heron Therapeutics receives expanded indications from the FDA for Zynrelef

Heron Therapeutics Inc. announced Zynrelef has received expanded indications from the FDA for use in soft tissue and additional orthopedic surgical procedures, according to a press release.

News
May 17, 2023
1 min read
Save

Liposomal bupivacaine decreases opioids in adolescents undergoing posterior spinal fusion

Liposomal bupivacaine decreases opioids in adolescents undergoing posterior spinal fusion

Results showed a postoperative pain management protocol with liposomal bupivacaine decreased opioids and length of stay and improved ambulation in patients with adolescent idiopathic scoliosis who underwent posterior spinal fusion.

News
March 09, 2023
1 min read
Save

Speaker: Lidocaine has more favorable complication profile for neuraxial anesthesia in THA

Speaker: Lidocaine has more favorable complication profile for neuraxial anesthesia in THA

LAS VEGAS — Compared with bupivacaine, lidocaine had a more favorable complication profile when used for neuraxial anesthesia in patients undergoing total hip arthroplasty, according to presented results.

News
February 17, 2023
1 min read
Save

Hypobaric lidocaine reduced time to discharge for patients undergoing outpatient TJA

Hypobaric lidocaine reduced time to discharge for patients undergoing outpatient TJA

DALLAS — For patients undergoing outpatient total hip or knee arthroplasty, hypobaric lidocaine significantly reduced time to discharge and physical therapy assessment compared with longer-acting spinal drugs or general anesthesia.

News
January 24, 2023
2 min read
Save

Combination bupivacaine, meloxicam may reduce pain, opioid use after TKA

Combination bupivacaine, meloxicam may reduce pain, opioid use after TKA

KOLOA, Hawaii — Results showed use of Zynrelef as part of a multimodal analgesia protocol may significantly reduce pain and opioid use after total knee arthroplasty.

News
August 16, 2021
1 min read
Save

Mepivacaine spinal anesthesia led to faster same-day discharge after THA vs bupivacaine

Mepivacaine spinal anesthesia led to faster same-day discharge after THA vs bupivacaine

Compared with bupivacaine spinal anesthesia, mepivacaine allowed for faster same-day discharge from an ASC with a minor increase in pain for patients undergoing total hip arthroplasty.

News
June 07, 2021
1 min read
Save

Ropivacaine shows ‘clear advantage’ vs bupivacaine for spinal anesthesia during THA

Ropivacaine shows ‘clear advantage’ vs bupivacaine for spinal anesthesia during THA

Compared with bupivacaine, patients who had ropivacaine had superior ambulation time and distance, quicker post-anesthesia care unit transition and a similar complication rate during total hip arthroplasty, according to published results.

News
May 24, 2021
2 min read
Save

Mepivacaine yielded early ambulation, more same-day discharge after THA

Use of mepivacaine for spinal anesthesia during total hip arthroplasty led to earlier ambulation and a greater percentage of same-day discharge compared with hyperbaric and isobaric bupivacaine, according to results.

News
May 13, 2021
1 min read
Save

Heron Therapeutics receives FDA approval for Zynrelef

Heron Therapeutics Inc. announced it received FDA approval for Zynrelef to provide postsurgical analgesia for up to 72 hours after bunionectomy, open inguinal herniorrhaphy and total knee arthroplasty.

View more